Chromosomal microarray analysis (CMA) detects a large X chromosome deletion including FMR1, FMR2, and IDS in a female patient with mental retardation
- PMID: 17506108
- DOI: 10.1002/ajmg.a.31781
Chromosomal microarray analysis (CMA) detects a large X chromosome deletion including FMR1, FMR2, and IDS in a female patient with mental retardation
Abstract
Chromosomal microarray analysis (CMA) by array-based comparative genomic hybridization (CGH) is a new clinical test for the detection of well-characterized genomic disorders caused by chromosomal deletions and duplications that result in gene copy number variation (CNV). This powerful assay detects an abnormality in approximately 7-9% of patients with various clinical phenotypes, including mental retardation. We report here on the results found in a 6-year-old girl with mildly dysmorphic facies, obesity, and marked developmental delay. CMA was requested and showed a heterozygous loss in copy number with clones derived from the genomic region cytogenetically defined as Xq27.3-Xq28. This loss was not cytogenetically visible but was seen on FISH analysis with clones from the region. Further studies confirmed a loss of one copy each of the FMR1, FMR2, and IDS genes (which are mutated in Fragile X syndrome, FRAXE syndrome, and Hunter syndrome, respectively). Skewed X-inactivation has been previously reported in girls with deletions in this region and can lead to a combined Fragile X/Hunter syndrome phenotype in affected females. X-inactivation and iduronate 2-sulfatase (IDS) enzyme activity were therefore examined. X-inactivation was found to be random in the child's peripheral leukocytes, and IDS enzyme activity was approximately half of the normal value. This case demonstrates the utility of CMA both for detecting a submicroscopic chromosomal deletion and for suggesting further testing that could possibly lead to therapeutic options for patients with developmental delay.
Similar articles
-
Deletion Xq27.3q28 in female patient with global developmental delays and skewed X-inactivation.BMC Med Genet. 2013 May 1;14:49. doi: 10.1186/1471-2350-14-49. BMC Med Genet. 2013. PMID: 23634718 Free PMC article.
-
Int22h-1/int22h-2-mediated Xq28 rearrangements: intellectual disability associated with duplications and in utero male lethality with deletions.J Med Genet. 2011 Dec;48(12):840-50. doi: 10.1136/jmedgenet-2011-100125. Epub 2011 Oct 8. J Med Genet. 2011. PMID: 21984752
-
FMR1 gene expansion, large deletion of Xp, and skewed X-inactivation in a girl with mental retardation and autism.Am J Med Genet A. 2010 May;152A(5):1273-7. doi: 10.1002/ajmg.a.33352. Am J Med Genet A. 2010. PMID: 20425835
-
The FMR2 gene, FRAXE and non-specific X-linked mental retardation: clinical and molecular aspects.Ann Hum Genet. 2000 Mar;64(Pt 2):95-106. doi: 10.1017/S0003480000007983. Ann Hum Genet. 2000. PMID: 11246464 Review.
-
The use of genomic microarrays to study chromosomal abnormalities in mental retardation.Ment Retard Dev Disabil Res Rev. 2005;11(4):279-85. doi: 10.1002/mrdd.20082. Ment Retard Dev Disabil Res Rev. 2005. PMID: 16240409 Review.
Cited by
-
De Novo Large Deletion Leading to Fragile X Syndrome.Front Genet. 2022 May 11;13:884424. doi: 10.3389/fgene.2022.884424. eCollection 2022. Front Genet. 2022. PMID: 35646065 Free PMC article.
-
Observation and prediction of recurrent human translocations mediated by NAHR between nonhomologous chromosomes.Genome Res. 2011 Jan;21(1):33-46. doi: 10.1101/gr.111609.110. Genome Res. 2011. PMID: 21205869 Free PMC article.
-
Bacterial artificial chromosome-emulation oligonucleotide arrays for targeted clinical array-comparative genomic hybridization analyses.Genet Med. 2008 Apr;10(4):278-89. doi: 10.1097/GIM.0b013e31816b4420. Genet Med. 2008. PMID: 18414211 Free PMC article.
-
Protein interactome reveals converging molecular pathways among autism disorders.Sci Transl Med. 2011 Jun 8;3(86):86ra49. doi: 10.1126/scitranslmed.3002166. Sci Transl Med. 2011. PMID: 21653829 Free PMC article.
-
Mosaicism for r(X) and der(X)del(X)(p11.23)dup(X)(p11.21p11.22) provides insight into the possible mechanism of rearrangement.Mol Cytogenet. 2008 Jul 25;1:16. doi: 10.1186/1755-8166-1-16. Mol Cytogenet. 2008. PMID: 18655707 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources